Skip to main content

Table 2 Weight and mesenchymal stem cell (MSC) dose for cats participating in the intravenous allogeneic cryopreserved MSC studies

From: Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies

Study

Stage

Weight in kg, median (range)

MSC dose in cells/kg, median (range)

Pilot study 1, n = 6

Before

4.8 (2.7 to 5.1)

4.1 × 105 (3.9 × 105 to 7.4 × 105)

After

4.8 (2.5 to 5.2)

 

Pilot study 2, n = 5

Before

4.8 (4.4 to 6.2)

8.3 × 105 (6.1 × 105 to 9.1 × 105)

After

4.8 (4.2 to 7.1)

 

Pilot study 3, n = 5

Before

4.8 (3.7 to 7.1)

8.4 × 105 (5.6 × 105 to 1.1 × 106)

 

After

4.8 (3.5 to 7.1)

 
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512